Clinical trials: Nasolabial Fold
Correction of Nasolabial Folds
A Randomized, Multicenter, Evaluator-Blinded, Active-Controlled, Parallel-Group Investigation to Evaluate the Performance and Safety of YVOIRE® Classic Plus Versus Comparator for Temporary Correction of Nasolabial Folds
A Study to Evaluate the Performance and Safety of YVOIRE Classic plus on NLF.
- Trial name
- NCT05106751
- Testing
- Hyaluronic acid dermal filler
- Where
- Germany
- Volunteers
- 104 people, healthy volunteers welcome
- Sponsor
- LG Chem
Nasolabial Folds, Glabellar Crease
Autologous Fibroblast Transplantation in Facial Deformities
Beautiful skin requires maintenance of proper care. Skin exercise, protections from direct sunlight or harsh wind, and maintaining a healthy diet are some of the ways of having a good and radiant skin.
- Conditions
- Nasolabial Folds, Glabellar Crease, Deep Wrinkles of the Forehead, Acne Scars
- Trial name
- NCT01115634
- Testing
- Fibroblast, fibroblast and gel
- Where
- Iran
- Volunteers
- 60 people
- Sponsor
- Royan Institute
Nasolabial Folds
A Study to Assess Adverse Events and Effectiveness of HAC 20L Injections in Adult Participants for the Treatment of Nasolabial Folds
Nasolabial folds (NLF) are the two skin folds that run from each side of the nose to the corners of the mouth. Prominent NLFs distort the contour of the midface, giving a fatigued and aged appearance.
- Trial name
- NCT06018987
- Testing
- No-Treatment Control, HAC 20L
- Where
- 10 sites in Germany
- Volunteers
- 61 people
- Sponsor
- AbbVie
Rhytids
A Study to Determine How Long Restylane® Will Last After Initial Treatment With 2 Different Re-treatment Schedules.
A total of 75 subjects will be enrolled into a 36 month study. Subjects will be treated with Restylane® on both sides of the face (nasolabial folds) at the first visit, on one side of the face at month 4.5 and on the other side…
- Trial name
- NCT00765583
- Testing
- Restylane
- Where
- 3 sites in United States
- Volunteers
- 75 people, healthy volunteers welcome
- Sponsor
- Medicis Aesthetics, Inc.
Nasolabial Fold Correction
To Evaluate the Safety and Efficacy of Poly-L-lactic Acid Implants for the Correction of Nasolabial Folds
The goal of this clinical trial is to evaluate the safety and effectiveness of a poly-L-lactic acid (PLLA) dermal implant for the correction of nasolabial folds.
- Trial name
- NCT07343141
- Testing
- FUYANMEI Poly-L-Lactic Acid, Sculptra®
- Where
- Taiwan
- Volunteers
- 121 people
- Sponsor
- SciVision Biotech Inc.
Nasolabial Fold, Safety
A Study to Evaluate the Performance and Safety of GP0045 for Correction of Moderate to Severe Nasolabial Folds
This is a study to assess the performance and safety of GP0045 when injected in the nasolabial folds. There is an 18 months follow up period.
- Trial name
- NCT03300466
- Testing
- GP0045, Comparator
- Where
- Sweden
- Volunteers
- 20 people, healthy volunteers welcome
- Sponsor
- Galderma R&D
Correction of Moderate to Severe Nasolabial Folds (NLFs)
Evaluation of the Effectiveness and Safety of Radiesse for the Correction of Moderate to Severe Nasolabial Folds
Effectiveness: The purpose of this study is to demonstrate the non-inferiority of Radiesse (CaHA) to Restylane (HA) following subdermal implantation for the correction of moderate to severe facial wrinkles and folds, such as…
- Trial name
- NCT04647721
- Testing
- Radiesse injectable implant (dermal filler), Restylane injectable implant (dermal filler)
- Where
- 7 sites in China
- Volunteers
- 134 people
- Sponsor
- Merz North America, Inc.
Nasolabial Fold, Hypoplastic
Safety Study of TPX-121 on Nasolabial Folds
Nasolabial folds augmentation is possible through dermal filler and botulinum toxin, however, safety issues are existed as well as efficacy. Therefore, there is a need for a safer procedure for nasolabial folds correction.
- Trial name
- NCT06533540
- Testing
- TPX-115(allogeneic fibroblasts)
- Where
- South Korea
- Volunteers
- 18 people
- Sponsor
- Tego Science, Inc.
Nasolabial Fold, Cheek Augmentation
Preliminary Safety and Effectiveness of SMI-01 as a Tissue Filler
Multicenter (two clinical sites), unblinded, no control group, prospective feasibility study. Subject participation may last up to 24 months after enrollment.
- Trial name
- NCT04534660
- Testing
- SMI-01
- Where
- 2 sites in United States
- Volunteers
- 21 people
- Sponsor
- Sofregen Medical, Inc.
Nasolabial Fold Wrinkles
DL6049 vs CosmoPlast in the Treatment of Nasolabial Fold Wrinkles
This study is being undertaken to: evaluate the degree of correction attainable with DL6049 (injectable poly-L-lactic acid)compared to a commercially available CosmoPlast™ Collagen Implant in the treatment of dermal nasolabial…
- Trial name
- NCT00444210
- Testing
- DL6049 (injectable poly-L-lactic acid)
- Where
- United States
- Volunteers
- 240 people
- Sponsor
- Bausch Health Americas, Inc.
Temporary Correction of Wrinkles
Clinical Study to Evaluate the Correction of Wrinkles and Folds and Safety of YVOIRE Classic Versus Restylane in Nasolabial Fold Intradermal Injection
This study was purposed to evaluate the non-inferiority of HA IDF, a hyaluronic acid product, in terms of correction of wrinkles and safety in nasolabial fold intradermal injection, compared to Restylane, the control preparation.
- Trial name
- NCT03738020
- Testing
- HA IDF (YVOIRE classic), Restylane
- Volunteers
- 58 people, healthy volunteers welcome
- Sponsor
- LG Life Sciences
Nasolabial Folds, Mid Face Volume Loss
Evaluate the Post-marketing Efficacy and Safety of Eptq S and Eptq Lidocaine S
This study in multi-center, prospective and observational study. The purpose of this study is to observe effects and safety of hyaluronic acid filler series, eptq S and eptq Lidocaine S, for facial volume and folds.
- Conditions
- Nasolabial Folds, Mid Face Volume Loss, Lip Volume Enhancement
- Trial name
- NCT06699147
- Testing
- Hyaluronic Acid (HA)
- Where
- South Korea
- Volunteers
- 238 people
- Sponsor
- Jetema Co., Ltd.
Nasolabial Folds
Efficacy and Safety of a 'Graft/Prosthesis, Biomaterial (DKM410)' in the Treatment of Both Nasolabial Folds
The purpose of the study is to assess the efficacy and safety of a 'Graft/prosthesis, biomaterial (DKM410)' in the treatment of both nasolabial folds.
- Trial name
- NCT05612958
- Testing
- DKM-410, Juvederm ULTRA PLUS XC 1.0ml
- Where
- South Korea
- Volunteers
- 82 people
- Sponsor
- Dongkook Pharmaceutical Co., Ltd.
Wrinkle
A Comparative Analysis of Two Hyaluronic Acid Fillers for Nasolabial Fold Correction
This is a randomized, split-face, subject-blinded, comparative study. Subjects will receive initial treatment with Defyne on one of the NLFs and with RHA3 on the other based on the pre-determined randomization.
- Trial name
- NCT06351293
- Testing
- Defyne Treatment in Nasolabial Fold, RHA3 Treatment in Nasolabial Fold
- Where
- United States
- Volunteers
- 15 people, healthy volunteers welcome
- Sponsor
- Galderma R&D
Wrinkles, Folds
A Clinical Investigation Comparing the Safety and Performance of RefillHA Solid With Hydryalix Ultra Deep Lidocaine for the Correction of Moderate-to-severe Nasolabial Folds
Prospective, controlled, randomized, monocentric, double-blind, split-face non-inferiority clinical study to evaluate the safety and performance of injectable implant based on hyaluronic acid hydrogel with lidocaine for…
- Trial name
- NCT07736703
- Where
- Israel
- Volunteers
- 12 people, healthy volunteers welcome
- Sponsor
- Glyance
Nasolabial Folds
Extension Study for 43USSA1705
To evaluate the long-term safety of Sculptra Aesthetic as a single regimen for correction of Nasolabial Fold (NLF) contour deficiencies after changes in reconstitution and injection procedures compared to the approved label.
- Trial name
- NCT04225273
- Testing
- Sculptra Aesthetic, Lidocaine HCL
- Where
- 4 sites in United States
- Volunteers
- 38 people
- Sponsor
- Galderma R&D
Correction of Nasolabial Folds
Post Market Study Evaluating Princess Filler Lidocaine for the Correction of Nasolabial Folds
In this study, eligible subjects with moderate to severe nasolabial folds will be treated with Princess® FILLER Lidocaine and will return for follow-up assessments 2, 4, 24 and 36 weeks after the treatment.
- Trial name
- FINO (NCT03611491)
- Testing
- Princess FILLER Lidocaine
- Where
- 2 sites in Austria
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- Croma-Pharma GmbH
Correction of Nasolabial Folds
Safety and Effectiveness of THIODERM STRONG in the Correction of Nasolabial Folds
This is a prospective, open label, dose-escalating, multicenter clinical investigation to evaluate the safety and effectiveness of THIODERM STRONG in the correction of nasolabial folds.
- Trial name
- NCT03650218
- Testing
- THIODERM STRONG
- Where
- 2 sites in Austria
- Volunteers
- 74 people, healthy volunteers welcome
- Sponsor
- Croma-Pharma GmbH
Nasolabial Folds
Neuramis® Deep Lidocaine Compared to YVOIRE® Volume Plus for Correction of Nasolabial Folds
This clinical investigation is a randomized, evaluator-blind, active controlled, noninferiority study to evaluate the effectiveness and safety of Neuramis® Deep Lidocaine when compared with YVOIRE® Volume Plus.
- Trial name
- NCT03753152
- Testing
- experimental, comparator
- Where
- China
- Volunteers
- 370 people, healthy volunteers welcome
- Sponsor
- Medy-Tox
Wrinkle Reduction
Filler Post Market Survey (FIPS)
This Post-Market Clinical Follow-Up (PMCF) survey aims to descriptively evaluate the clinical performance and safety of saypha® filler when used under routine clinical practice for the correction of moderate to severe nasolabial…
- Trial name
- FIPS (NCT07475455)
- Testing
- Hyaluronic acid dermal filler (routine clinical use)
- Where
- Austria
- Volunteers
- 33 people
- Sponsor
- Croma-Pharma GmbH